UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats

Regulatory peptides, 2000-12, Vol.96 (1), p.7-16

2000

Volltextzugriff (PDF)

Phosphinic Acid Analogs of GABA. 2. Selective, Orally Active GABAB Antagonists

Journal of medicinal chemistry, 1995-08, Vol.38 (17), p.3313-3331

1995

Volltextzugriff (PDF)

An Examination of the Predictive Relationship between Mode of Instruction and Student Success in Introductory Biology

Hauser, Lynette Kathleen

2013

Volltextzugriff (PDF)

Dual neurokinin NK1/NK2 antagonists : N-[(R, R)-(E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis( trifluoromethyl)benzamides and 3-[N'-3,5-bis(trifluoromethyl)benzoyl-N-arylmethyl-N'-methylhydrazino]-N-[(R)-2- oxo-azepan-3-yl]propionamides

Bioorganic & medicinal chemistry letters, 2001-12, Vol.11 (23), p.3081-3084

2001

Volltextzugriff (PDF)

SAR of 2-benzyl-4-aminopiperidines: CGP 49823, an orally and centrally active non-peptide NK1 antagonist

Bioorganic & medicinal chemistry letters, 1996-07, Vol.6 (14), p.1623-1628

1996

Volltextzugriff (PDF)

Studies on the active conformation of the NK1 antagonist CGP 49823. Part 2. Fluoro-olefin analogs of tertiary amide rotamers

Bioorganic & medicinal chemistry letters, 1997-02, Vol.7 (3), p.351-354

1997

Volltextzugriff (PDF)

Studies on the active conformation of the NK1 antagonist CGP 49823. Part 21. Fluoro-olefin analogs of tertiary amide rotamers

Bioorganic & medicinal chemistry letters, 1997-02, Vol.7 (3), p.351-354

1997

Volltextzugriff (PDF)

Studies on the active conformation of NK 1 antagonist CGP 49823. Part 1. Synthesis of conformationally restricted analogs

Bioorganic & medicinal chemistry letters, 1997, Vol.7 (3), p.347-350

1997

Volltextzugriff (PDF)

Studies on the active conformation of the NK 1 antagonist CGP 49823. Part 2 1. Fluoro-olefin analogs of tertiary amide rotamers

Bioorganic & medicinal chemistry letters, 1997, Vol.7 (3), p.351-354

1997

Volltextzugriff (PDF)

Topography of substantia nigra innervation by D1 receptor-containing striatal neurons

Brain research, 1987-04, Vol.410 (1), p.1-11

1987

Volltextzugriff (PDF)

Studies on the active conformation of NK1 antagonist CGP 49823. Part 1. Synthesis of conformationally restricted analogs

Bioorganic & medicinal chemistry letters, 1997-02, Vol.7 (3), p.347-350

1997

Volltextzugriff (PDF)

N-[(R, R)-(E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl- 3,5-bis-trifluoromethyl-benzamide : An orally active neurokinin NK1/NK2 antagonist

Bioorganic & medicinal chemistry letters, 2000-07, Vol.10 (13), p.1467-1470

2000

Volltextzugriff (PDF)

N-[( R,R)-( E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]- N-methyl-3,5-bis-trifluoromethyl-benzamide: an orally active neurokinin NK 1/NK 2 antagonist

Bioorganic & medicinal chemistry letters, 2000, Vol.10 (13), p.1467-1470

2000

Volltextzugriff (PDF)

Dual neurokinin NK 1/NK 2 antagonists: N-[( R, R)-( E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl- N-methyl-3,5-bis(trifluoromethyl)benzamides and 3-[ N′-3,5-bis(trifluoromethyl)benzoyl- N-arylmethyl- N′-methylhydrazino]- N-[( R)-2-oxo-azepan-3-yl]propionamides

Bioorganic & medicinal chemistry letters, 2001, Vol.11 (23), p.3081-3084

2001

Volltextzugriff (PDF)

SAR of 2-benzyl-4-aminopiperidines NK1 antagonists. Part 21. synthesis of CGP 49823

Bioorganic & medicinal chemistry letters, 1996-12, Vol.6 (24), p.3029-3034

1996

Volltextzugriff (PDF)

SAR of 2-benzyl-4-aminopiperidines: CGP 49823, an orally and centrally active non-peptide NK 1 antagonist

Bioorganic & medicinal chemistry letters, 1996, Vol.6 (14), p.1623-1628

1996

Volltextzugriff (PDF)

SAR of 2-benzyl-4-aminopiperidines NK 1 antagonists. Part 2 1. synthesis of CGP 49823

Bioorganic & medicinal chemistry letters, 1996, Vol.6 (24), p.3029-3034

1996

Volltextzugriff (PDF)

Topography of substantia nigra innervation by D 1 receptor-containing striatal neurons

Brain research, 1987, Vol.410 (1), p.1-11

1987

Volltextzugriff (PDF)

[ 3H]Substance P binds to two high-affinity sites in bovine retina

Regulatory peptides, 1993-07, Vol.46 (1), p.340-342

1993

Volltextzugriff (PDF)

CGP57698: a structurally simple, highly potent peptido-leukotriene (pLT) antagonist of the quinoline type

Advances in experimental medicine and biology, 1997, Vol.433, p.169

1997

Volltextzugriff (PDF)

Subchronic infusion of clenbuterol, a beta-adrenergic agonist, decreases the cerebellar beta receptor

Neuroscience letters, 1983-03, Vol.36 (1), p.93-97

1983

Volltextzugriff (PDF)

Developmental changes in high-affinity uptake of GABA by cultured neurons

Neurochemical research, 1989-03, Vol.14 (3), p.229-233

1989

Volltextzugriff (PDF)

Trimipramine, a tricyclic antidepressant exerting atypical actions on the central noradrenergic system

European journal of pharmacology, 1985-01, Vol.111 (1), p.23-30

1985

Volltextzugriff (PDF)

Reversal by apomorphine of the gabaculine-induced GABA accumulation in mouse cortex

European journal of pharmacology, 1989-12, Vol.174 (2), p.161-170

1989

Volltextzugriff (PDF)

Ifoxetine, a compound with atypical effects on serotonin uptake

European journal of pharmacology, 1986-10, Vol.130 (1), p.1-10

1986

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(122)
Mit Volltextzugriff
(117)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(140)
Deutsch
(1)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(80)
Life Sciences & Biomedicine
(72)
Humans
(54)
Male
(45)
Female
(42)
Biological And Medical Sciences
(35)
Medical Sciences
(28)
Middle Aged
(23)
Animals
(20)
Adult
(19)
Neurosciences & Neurology
(16)
Aged
(14)
Neurology
(14)
Clinical Neurology
(13)
Biochemistry & Molecular Biology
(11)
Genetics & Heredity
(10)
Fundamental And Applied Biological Sciences. Psychology
(9)
Prospective Studies
(9)
Rats
(9)
Child, Preschool
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats

Phosphinic Acid Analogs of GABA. 2. Selective, Orally Active GABAB Antagonists

An Examination of the Predictive Relationship between Mode of Instruction and Student Success in Introductory Biology

Dual neurokinin NK1/NK2 antagonists : N-[(R, R)-(E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis( trifluoromethyl)benzamides and 3-[N'-3,5-bis(trifluoromethyl)benzoyl-N-arylmethyl-N'-methylhydrazino]-N-[(R)-2- oxo-azepan-3-yl]propionamides

SAR of 2-benzyl-4-aminopiperidines: CGP 49823, an orally and centrally active non-peptide NK1 antagonist

Studies on the active conformation of the NK1 antagonist CGP 49823. Part 2. Fluoro-olefin analogs of tertiary amide rotamers

Studies on the active conformation of the NK1 antagonist CGP 49823. Part 21. Fluoro-olefin analogs of tertiary amide rotamers

Studies on the active conformation of NK 1 antagonist CGP 49823. Part 1. Synthesis of conformationally restricted analogs

Studies on the active conformation of the NK 1 antagonist CGP 49823. Part 2 1. Fluoro-olefin analogs of tertiary amide rotamers

Topography of substantia nigra innervation by D1 receptor-containing striatal neurons

Studies on the active conformation of NK1 antagonist CGP 49823. Part 1. Synthesis of conformationally restricted analogs

N-[(R, R)-(E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl- 3,5-bis-trifluoromethyl-benzamide : An orally active neurokinin NK1/NK2 antagonist

N-[( R,R)-( E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]- N-methyl-3,5-bis-trifluoromethyl-benzamide: an orally active neurokinin NK 1/NK 2 antagonist

Dual neurokinin NK 1/NK 2 antagonists: N-[( R, R)-( E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl- N-methyl-3,5-bis(trifluoromethyl)benzamides and 3-[ N′-3,5-bis(trifluoromethyl)benzoyl- N-arylmethyl- N′-methylhydrazino]- N-[( R)-2-oxo-azepan-3-yl]propionamides

SAR of 2-benzyl-4-aminopiperidines NK1 antagonists. Part 21. synthesis of CGP 49823

SAR of 2-benzyl-4-aminopiperidines: CGP 49823, an orally and centrally active non-peptide NK 1 antagonist

SAR of 2-benzyl-4-aminopiperidines NK 1 antagonists. Part 2 1. synthesis of CGP 49823

Topography of substantia nigra innervation by D 1 receptor-containing striatal neurons

[ 3H]Substance P binds to two high-affinity sites in bovine retina

CGP57698: a structurally simple, highly potent peptido-leukotriene (pLT) antagonist of the quinoline type

Subchronic infusion of clenbuterol, a beta-adrenergic agonist, decreases the cerebellar beta receptor

Developmental changes in high-affinity uptake of GABA by cultured neurons

Trimipramine, a tricyclic antidepressant exerting atypical actions on the central noradrenergic system

Reversal by apomorphine of the gabaculine-induced GABA accumulation in mouse cortex

Ifoxetine, a compound with atypical effects on serotonin uptake

Suchergebnisse filtern